Hundreds have reported pancreatic issues linked to GLP-1 receptor agonists, with ten deaths associated, prompting a new study to explore potential genetic risk factors. As GPs begin prescribing weight loss jabs like Mounjaro to patients with a BMI of 40+, the MHRA is collecting data on side effects to improve safety and effectiveness.
Explain It To Me Like I’m 5: Many people are having problems with their pancreas after using weight loss injections, and doctors are trying to find out if some people might be more at risk because of their genes.
Want More Context? 🔎
